Table 3.
Model | Type | Tissue sites | Effects | Mechanisms | RF |
---|---|---|---|---|---|
d MCAO in mice OGD-induced hCMEC/D3 cells |
In vivo In vitro |
Ischemic stroke | ↑ neurobehavioral outcomes ↓ brain infarct volume ↑ CD31 expression ↑ BrdU+/CD31+ microvessels ↑ GFAP-positive vessels ↑ proliferation, migration, and tube formation of endothelial cells |
↑ VEGF, HIF-1α, PI3K, p-AKT, and p-mTOR expression ↑ PI3K/AKT/mTOR signaling pathway |
[85] |
t MCAO in rats OGD/R-induced PC12 cells |
In vivo In vitro |
I/R-induced neuronal injury | ↓ cell injury ↓ MiR-144 activity Prolong Nrf2 nuclear accumulation ↑ Nrf2 transcriptional activity ↑ ARE-targeted genes expression |
↓ oxidative stress ↑ Nrf2/ARE Pathway ↓ MiR-144 activity |
[86] |
MCAO in mice | In vivo | Cerebral I/R injury | ↓ infarct volume ↓ neurological deficit scores ↓ IL-1ß, TNF-α, and IL-6 contents ↓ Glu and Asp contents |
↑ BDNF expression ↓ IL-1ß, IL-6, and TNF-α expression ↓ Glu and Asp contents |
[89] |
OGD-insulted NSCs | In vitro | Ischemic stroke | ↓ NSC viability ↓ OGD-induced apoptosis ↓ cleaved caspase-3 and Bax expression ↑ Bcl-2 expression |
↓ oxidative stress ↓ p38/JNK2 phosphorylation |
[87] |
MCAO/reperfusion in rats | In vivo | Cerebral I/R injury | ↑ neurobehavioral function ↓ infarct volume ↓ BBB permeability |
↓ PAR-1 expression | [88] |
MCAO in rats | In vivo | Cerebral I/R injury | ↓ infarct volume ↓ neurological deficit ↓ proinflammatory cytokine expressions ↓ proteasomal activity ↓ protein aggregate accumulation |
↓ NF-κB nuclear translocation ↓ IκBα phosphorylation ↓ ubiquitinated aggregates ↓ inflammatory response |
[90] |
RF: reference; other abbreviations as shown in the literature. (↓): downregulation or inhibition; (↑): upregulation or activation.